Venu Bathini

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Philip A. Philip, Jill Lacy, Fabienne Portales et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 246 citations

Medicine, Oncology, Pharmacology +10

Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status

Xiaoqin Zhu, Sarah Jamshed, Jian Zou et al. · Modern Pathology · 2021 · 39 citations · Full text

Medicine, Oncology, Pathology +17

Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Bilal Piperdi, Kendra Bradley, Zheng Zhou et al. · Journal of Thoracic Oncology · 2012 · 32 citations · Full text

Medicine, Oncology, Pharmacology +14

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non–small-cell Lung Cancer

Tianhong Li, Bilal Piperdi, Mimi Kim et al. · Clinical Lung Cancer · 2016 · 26 citations · Full text

Medicine, Oncology, Pharmacology +13

Interim results of a randomized phase II study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer.

Sunil R. Hingorani, William Proctor Harris, Tara Elisabeth Seery et al. · Journal of Clinical Oncology · 2016 · 25 citations

Medicine, Oncology, Pharmacology +17